APPLICATION NOTE

Revolutionizing antibody discovery: Next-generation hybridoma technology

Accelerating high-specificity antibody production with advanced screening

Breaking new ground in hybridoma development

Empowering researchers to identify superior virus-specific antibodies

Unlock the future of antibody discovery with the ClonePix and CloneSelect Imager, designed to redefine hybridoma development for virus-specific antibodies. This breakthrough technology offers:

Streamlined Screening: Immensely increases the capacity to identify high-titer antibody producers.
Elevated Production: Enhances hybridoma development for superior antibody titer levels.
Optimal Clone Identification: Raises the likelihood of finding high-secreting clones with advanced imaging.
Accelerated Development: Cuts monoclonal antibody generation time by up to 50%.
Consistent High Yields: Achieves uniform antibody production across selected clones.
Experience the efficiency and precision of the ClonePix and CloneSelect Imager in pushing the boundaries of therapeutic antibody development against ds-DNA viruses.

Heading

Download Application Note

Product family

ClonePix

Product primary application

ClonePix 2 System; CloneSelect Imager

CMP

701Rn00000Az4oyIAB

Title

Revolutionizing antibody discovery: Next-generation hybridoma technology

Resource URL

Resource Link